LONDON, May 11 (Reuters) - Britain's GlaxoSmithKline , which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.
* says March-quarter net profit 1.97 billion rupees Source text: http://bit.ly/1F3DFqP
LONDON, May 7 (Reuters) - GlaxoSmithKline 's new chairman Philip Hampton has thrown his support behind the company's current structure and chief executive despite pressure from some shareholders for a...
LONDON, May 7 (Reuters) - GlaxoSmithKline 's new chairman Philip Hampton expressed support for the company's current structure and its chief executive on Thursday while speaking to reporters after the drugmaker's annual meeting.
LONDON, May 6 (Reuters) - After relying for years on its top-selling lung drug Advair, GlaxoSmithKline is now braced for the worst in the form of cheap generics - but not just yet.
* Ceo says ~has different view from other companies on further drug pricing pressures
LONDON, May 6 (Reuters) - GlaxoSmithKline laid out growth targets for its biggest businesses on Wednesday, hoping to convince investors that focusing on consumer health and vaccines would return the drugmaker to long-term growth.
* Group revenue expected to grow at a cagr of low-to-mid single digits over five year period 2016-2020 on cer basis
LONDON, May 5 (Reuters) - GlaxoSmithKline said on Tuesday it had submitted a gene therapy for approval in Europe, becoming the first big drugmaker to seek marketing authorisation for the technology to fix faulty genes.
April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said.